honokiol has been researched along with Invasiveness, Neoplasm in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
Aghi, MK; Chandra, A; Chen, W; Diaz, AA; Garcia, JH; Gilbert, LA; Jahangiri, A; Jain, S; Joshi, RS; Kumar, S; Lin, JG; Müller, S; Nguyen, AT; Pereira, MP; Rick, JW; Shah, SS; Wadhwa, H; Weiss, J; Wolf, KJ; Yagnik, G | 1 |
Cha, EY; Ko, YB; Lee, JS; Lee, MS; Park, JB; Sul, JY | 1 |
Katiyar, SK; Singh, T | 1 |
Chang, KC; Eun, SY; Joo, YN; Kim, HJ; Lee, JH; Park, SW | 1 |
Bai, P; Bian, Y; Cheng, Z; Liang, L; Wan, J; Wang, F; Wang, S; Xue, F | 1 |
Chao, TH; Chiu, CS; Jan, YJ; Lai, DW; Lee, WJ; Liu, CY; Liu, SH; Pan, HC; Peng, YC; Sheu, ML; Tien, HR; Wu, SM | 1 |
Castillo, V; Cheng, S; Eliaz, I; Sliva, D | 1 |
Arbiser, JL; Avtanski, DB; Bonner, MY; Kuppusamy, P; Nagalingam, A; Saxena, NK; Sharma, D | 1 |
Chang, C; Cui, Y; Eliaz, I; Guo, H; Huang, R; Huang, X; Li, Y; Shen, B; Shen, L; Song, J; Yan, J; Ye, C; Ying, H; Zhang, Q; Zhao, W; Zhuang, J | 1 |
Arbiser, JL; Bonner, MY; Nagalingam, A; Saxena, NK; Sharma, D | 1 |
Ikeda, K; Nagase, H; Sakai, Y | 1 |
12 other study(ies) available for honokiol and Invasiveness, Neoplasm
Article | Year |
---|---|
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biphenyl Compounds; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chitinase-3-Like Protein 1; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Tumor Microenvironment; Up-Regulation; Xenograft Model Antitumor Assays; Young Adult; Zinc Finger E-box-Binding Homeobox 1 | 2020 |
Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Activation; Female; Humans; Lignans; Mice; Models, Biological; Neoplasm Invasiveness; NIH 3T3 Cells; Ovarian Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay | 2019 |
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
Topics: beta Catenin; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drugs, Chinese Herbal; Gene Knockdown Techniques; Humans; Lignans; Lung Neoplasms; Neoplasm Invasiveness; RNA Interference; Signal Transduction; Sulfonamides; Transcription Factor RelA | 2013 |
Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition.
Topics: Apoptosis; Biphenyl Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Endothelial Cells; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lignans; Neoplasm Invasiveness; Vascular Cell Adhesion Molecule-1 | 2014 |
[Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
Topics: Adult; Animals; Biomarkers, Tumor; Biphenyl Compounds; Calpain; Calreticulin; Cell Death; Cell Line, Tumor; Down-Regulation; Endoplasmic Reticulum Stress; Epithelial-Mesenchymal Transition; Female; Gene Knockdown Techniques; Humans; Lignans; Macrophages; Male; Methylnitronitrosoguanidine; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Neoplasm Invasiveness; Phagocytosis; PPAR gamma; Promoter Regions, Genetic; Protein Binding; Stomach Neoplasms; Up-Regulation | 2015 |
Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kisspeptins; Lignans; Neoplasm Invasiveness; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Signal Transduction | 2015 |
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Drugs, Chinese Herbal; Female; Histone Deacetylases; Humans; Leptin; Lignans; Magnolia; MCF-7 Cells; Mice; Mice, Nude; Mice, Obese; MicroRNAs; Neoplasm Invasiveness; Obesity; Phosphorylation; Plant Extracts; Promoter Regions, Genetic; Repressor Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Wnt1 Protein; Xenograft Model Antitumor Assays | 2015 |
Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Binding Sites; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lignans; Male; Matrix Metalloproteinase 9; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplastic Stem Cells; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Signal Transduction; SOXB1 Transcription Factors; Time Factors; Transcription, Genetic; Tumor Burden; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Enzyme Activation; Female; Gene Expression; Humans; Lignans; Mice; Mice, Nude; Neoplasm Invasiveness; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Spheroids, Cellular; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Fibrosarcoma; Humans; Lignans; Magnoliaceae; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Phytotherapy; Plant Bark; Tumor Cells, Cultured | 2001 |